Background: Graves' disease which consists of goiter with excessive discharge of thyroid hormones also has important extra thyroid manifestation. Thyroid dermopathy (pretibial myxedema) is an autoimmune phenomenon of Graves' disease. In fact the extrathyroidal manifestations of this form of thyrotoxicosis are due to immunologically mediated activation of fibroblasts in the extraocular muscles and the skin, with accumulation of glycosaminoglycans, leading to trapping of water and edema. This study highlights the pretibial region changes under light microscopy in known Graves' disease patients.
Introduction
Graves' disease is the commonest type of thyrotoxicosis accounting for 60-80% of the cases and consists of one or more of the fol-lowing characteristics: goiter with hyperthyroidism, exophthalmos, thyroid dermopathy and acropachy [1] . Often such patients present to the physician with features of hyperthyroidism without any other apparent clinical feature. At other times a proper examination of the extremities and the eyes are missed thus overlooking vital signs of pretibial myxedema and exophthalmos which would give important information about the disease. Finding of thickened skin over the lower legs often with non pitting edema is essential in the context of diagnosis of Graves' disease and may indicate advanced stage of the disease. A finding of this lesion can prompt the physician to institute early therapeutic measures against thyrotoxicosis.
Materials and Methods
This study was conducted in the Department of Dermatology of a tertiary care Hospital in Kolkata. This is an ongoing prospective study, and results of 1 year are being reported. All patients (from study date) fulfilling the inclusion criteria and attending the Endocrinology OPD and subsequently the Dermatology OPD will be included in the study. These patients are interviewed and examined clinically and a small punch biopsy taken for histopathological examination. This is an observational cross sectional study. 30 patients examined and data obtained were recorded in a Proforma.
Inclusion criteria:
Patients fulfilling the criteria of Graves' disease with or without clinical evidence of extrathyroid manifestation.
Exclusion criteria: Patients fulfilling the inclusion criteria but presenting some other lesion over pretibial region. A patient however could consent partly i.e. for providing history and clinical examination but unwilling to do skin biopsy.
Results
Out of 30 patients of Graves' disease 17 were male and 13 were female (1.3:1). Most of the patients were middle aged adult, mean age was 39.5 years (Figure 1) . Among the patients clinically evident pretibial myxedema were present in 13.3% cases and female to male ratio was 1:1. Development of clinically significant pretibial myxedema (found in 4 patients) is usually late and most patients developed more than 1 year after diagnosis of Graves' disease. But microscopical changes started to occur much earlier. About 26.6 % cases developed some changes in the pretibial region before 1 year of diagnosis of Graves' disease. Among all patients 16.67% cases had changes in their epidermis while dermal changes were found in 33.33% of cases (Tables 1 and 2). Those patients who had clinical thyroid dermopathy over pretibial region had very high level of T4 (148-470 mg/dl) and in contrast T3 were high in patients without that clinical finding ( Table 3 ). 25% cases of frank pretibial myxedema patients were associated with exophthalmos (Figure 2 ).
Discussion
Thyroid dermopathy is generally known as pretibial myxedema though the immunologically mediated deposit of glycosaminoglycans may occur at sites other than pretibial region. The hypothesis of immunological factor is well known but other scientists have presented the reasoning that these lesions are the result of local factors superimposed on chronic low grade inflammation [2] . Thyroid dermopathy occurs in <5% of cases of Graves' disease [3] . In our study prevalence of pretibial myxedema is 13.3% of total Graves' disease patients. Male to female ratio in developing pretibial myxedema is 3.5:1 [4] . But in our present study we found it is 1:1. Though asymptomatic and having only cos- metic importance the lesions usually occur in late stage of the ailment often accompanied with severe ophthalmopathy [5] . Thyroid dermopathy typically develops 12 to 24 months after the diagnosis of thyrotoxicosis [6] . Pretibial myxedema can at times herald the onset of the disease and is known to occur in the absence of ophthalmopathy [7] . In our study we found patients having frank pretibial myxedema were asymptomatic and usually manifested later more than 1 year after diagnosis of Graves' disease. Also there was lesser association of ophthalmopathy with pretibial myxedema than documented (25%). Pretibial myxedema usually presents with brawny non edematous swelling on the lower legs typically known as 'orange skin appearance' but has also been reported to occur over the upper extremities [4] . Nodular and plaque forms can occur. Polypoidal type of this disorder is a rare variety, as is Elephantiasis Nostras Verrucosa which has been reported from our country [8] . This last type manifests as huge elongated mass over the lower part of the legs.
Where thyrotrophin and free thyroxin are the most used tests in invitro diagnosis of Graves' disease, tibial dermopathy mostly has been diagnosed clinically. No specific relation with level of thyroid hormones has been mentioned in the literature. In our study we found that patients who had clinical evidence of pretibial myxedema also had significantly eleva-ted level of thyrotropin. Histology has been used in some cases to confirm the diagnosis while pretibial ultrasound was used to diagnose this disorder in one other case [9] . On histopathology of the pretibial region we found epidermal changes in 16.67 % and dermal changes in 33.33% of cases of Graves' disease with or without clinical myxedema.
Topical potent Glucocorticoid application often under occlusion has been the main stay in treating this sort of edema though the beneficial effects of such therapy on long term remission of pretibial myxedema has been questioned in some studies [10] . We also treated our cases with potent topical steroid with appreciable clinical improvement.
Conclusion
This study shows pretibial myxedema or thyroid dermopathy is a late manifestation of Graves' disease (more than 1 year) with mean age 39.5 years with equal sex distribution. Pretibial myxedema is associated with high level of circulating thyroid hormone and occasionally not always preceded by ophthalmopathy. 
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